Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the month of April 2023, with the report signed on May 9, 2023. The filing is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002 regarding transactions with securities and derivatives.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on treasury share transactions.
| Metric | Value |
|---|---|
| Treasury Shares (Initial Balance) | 7,859,137 |
| Treasury Shares (Final Balance) | 5,880,900 |
| Shares Delivered (Restricted) | 1,978,237 |
| Transaction Price per Share | R$ 14.66 |
| Total Transaction Volume | R$ 29,000,954.42 |
Material Changes
The primary material change reported is a reduction in the company's outstanding shares held in treasury. During April 2023, Ambev S.A. executed a direct transaction with the company involving the delivery of 1,978,237 restricted common shares. This transaction reduced the treasury share balance from 7,859,137 to 5,880,900.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, risk factors, contingencies, or unusual items. The scope is limited to the disclosure of specific securities transactions required by Brazilian regulatory instruction.
Investor Verification Checklist
- Verify the impact of the 1,978,237 restricted share delivery on the company's total share count and earnings per share.
- Confirm the identity of the recipient of the restricted shares, as the filing lists the transaction as "Direct with the Company" but does not explicitly name the counterparty in the provided text.
- Review the company's broader capital allocation strategy to understand the context of this treasury share reduction.